BLAC (Bellevue Life Sciences Acquisition) EV-to-Revenue : (As of May. 28, 2025)

Bellevue Life Sciences Acquisition EV-to-Revenue Chart

Bellevue Life Sciences Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Bellevue Life Sciences Acquisition's EV-to-Revenue

For the Shell Companies subindustry, Bellevue Life Sciences Acquisition's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bellevue Life Sciences Acquisition's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Bellevue Life Sciences Acquisition's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bellevue Life Sciences Acquisition's EV-to-Revenue falls into.

Bellevue Life Sciences Acquisition EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bellevue Life Sciences Acquisition's EV-to-Revenue for today is calculated as:

Bellevue Life Sciences Acquisition's current Enterprise Value is $8.75 Mil.
Bellevue Life Sciences Acquisition's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bellevue Life Sciences Acquisition  (NAS:BLAC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bellevue Life Sciences Acquisition's PS Ratiofor today is calculated as:

Bellevue Life Sciences Acquisition's share price for today is $3.01.
Bellevue Life Sciences Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bellevue Life Sciences Acquisition EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bellevue Life Sciences Acquisition Business Description